| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | USD | 376.000 | 8.30 | Aaa | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+65 | - | - |
| B | USD | 29.500 | 10.00 | Aa2 | AA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+165 | - | - |
| C | USD | 25.250 | 10.20 | A2 | A | - | - | - | - | - | Floating | 3mL | - | - | 3mL+275 | - | - |
| D | USD | 19.250 | 10.30 | Baa2 | BBB | - | - | - | - | - | Floating | 3mL | - | - | 3mL+525 | - | - |
| E | USD | 17.250 | 10.50 | Ba2 | BB | - | - | - | - | - | Floating | 3mL | - | - | 3mL+950 | - | - |
| Equity | USD | 48.000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Explore all other research.